NO173996C - Analogifremgangsmaate for fremstilling av selektive adenosinreseptormidler - Google Patents

Analogifremgangsmaate for fremstilling av selektive adenosinreseptormidler

Info

Publication number
NO173996C
NO173996C NO901423A NO901423A NO173996C NO 173996 C NO173996 C NO 173996C NO 901423 A NO901423 A NO 901423A NO 901423 A NO901423 A NO 901423A NO 173996 C NO173996 C NO 173996C
Authority
NO
Norway
Prior art keywords
carbon atoms
adenosine
adenosine receptor
hydrogen
proviso
Prior art date
Application number
NO901423A
Other languages
English (en)
Norwegian (no)
Other versions
NO901423D0 (no
NO901423L (no
NO173996B (no
Inventor
Norton Paul Peet
Shyam Sunder
Nelson Lowell Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO901423D0 publication Critical patent/NO901423D0/no
Publication of NO901423L publication Critical patent/NO901423L/no
Publication of NO173996B publication Critical patent/NO173996B/no
Publication of NO173996C publication Critical patent/NO173996C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO901423A 1989-03-29 1990-03-28 Analogifremgangsmaate for fremstilling av selektive adenosinreseptormidler NO173996C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32991989A 1989-03-29 1989-03-29

Publications (4)

Publication Number Publication Date
NO901423D0 NO901423D0 (no) 1990-03-28
NO901423L NO901423L (no) 1990-10-01
NO173996B NO173996B (no) 1993-11-22
NO173996C true NO173996C (no) 1994-03-02

Family

ID=23287579

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901423A NO173996C (no) 1989-03-29 1990-03-28 Analogifremgangsmaate for fremstilling av selektive adenosinreseptormidler

Country Status (18)

Country Link
EP (1) EP0390112B1 (de)
JP (1) JP2954971B2 (de)
KR (1) KR0168647B1 (de)
CN (1) CN1034575C (de)
AT (1) ATE162791T1 (de)
AU (1) AU630439B2 (de)
CA (1) CA2013380C (de)
DE (1) DE69031989T2 (de)
DK (1) DK0390112T3 (de)
ES (1) ES2114524T3 (de)
FI (1) FI95910C (de)
GR (1) GR3026173T3 (de)
HU (1) HU206354B (de)
IL (1) IL93892A (de)
NO (1) NO173996C (de)
NZ (1) NZ233078A (de)
PT (1) PT93588B (de)
ZA (1) ZA902280B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
EP0644935A1 (de) * 1992-06-12 1995-03-29 Garvan Institute Of Medical Research DNA SEQUENZEN KODIERENDE FÜR DIE HUMANEN A1, A2a UND A2b-ADENOSINREZEPTOREN
FR2741881B1 (fr) 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
WO2000063703A1 (en) 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
GB0100621D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VI
KR100468352B1 (ko) * 2002-09-24 2005-01-27 한국과학기술연구원 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
EP1615930A2 (de) 2003-04-09 2006-01-18 Biogen Idec MA, Inc. Als a2a-adenosinrezeptor-antagonisten geeignete triazolotriazine und pyrazolotriazine
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
WO2004092173A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
JP2015172077A (ja) * 2015-06-24 2015-10-01 中国医学科学院葯物研究所 Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途
AU2018257332B2 (en) * 2017-04-27 2021-11-04 Takeda Pharmaceutical Company Limited Heterocyclic compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE601946A (de) * 1960-03-31
NL283192A (de) * 1961-09-14
NL128629C (de) * 1966-05-07
DE1795828A1 (de) * 1966-12-21 1975-11-27 Boehringer Mannheim Gmbh Adenosinderivate
DE2139107A1 (de) * 1971-08-04 1973-02-15 Merck Patent Gmbh Heterocyclisch substituierte adenosinverbindungen
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
AU527013B2 (en) * 1979-01-10 1983-02-10 Imperial Chemical Industries Ltd. Pure during derivatives and defoliation of cotton
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
EP0300144A3 (de) * 1984-04-18 1989-09-27 Whitby Research Incorporated N-6-Alkyl substituierte Adenosinderivate als herzwirksame Vasodilatoren
AU575438B2 (en) * 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3712735A1 (de) * 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
WO1990009178A1 (en) * 1989-01-31 1990-08-23 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists

Also Published As

Publication number Publication date
PT93588B (pt) 1996-08-30
ATE162791T1 (de) 1998-02-15
JP2954971B2 (ja) 1999-09-27
EP0390112B1 (de) 1998-01-28
KR900014389A (ko) 1990-10-23
CN1034575C (zh) 1997-04-16
NO901423D0 (no) 1990-03-28
CA2013380A1 (en) 1990-09-29
FI95910B (fi) 1995-12-29
ZA902280B (en) 1990-12-28
EP0390112A2 (de) 1990-10-03
NO901423L (no) 1990-10-01
HU206354B (en) 1992-10-28
DE69031989D1 (de) 1998-03-05
ES2114524T3 (es) 1998-06-01
EP0390112A3 (de) 1992-02-12
AU630439B2 (en) 1992-10-29
FI901549A0 (fi) 1990-03-28
IL93892A (en) 1994-11-28
DK0390112T3 (da) 1998-09-23
HUT53648A (en) 1990-11-28
DE69031989T2 (de) 1998-09-03
CA2013380C (en) 2001-05-22
CN1045973A (zh) 1990-10-10
FI95910C (fi) 1996-04-10
NZ233078A (en) 1993-11-25
NO173996B (no) 1993-11-22
GR3026173T3 (en) 1998-05-29
PT93588A (pt) 1990-11-20
HU901856D0 (en) 1990-08-28
KR0168647B1 (ko) 1999-01-15
JPH02289570A (ja) 1990-11-29
AU5221590A (en) 1990-10-04

Similar Documents

Publication Publication Date Title
NO173996C (no) Analogifremgangsmaate for fremstilling av selektive adenosinreseptormidler
ES2007411A6 (es) Procedimiento de preparar nuevos agentes psicoestimulantes.
CA2038747A1 (en) Selective adenosine receptor agents
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
EP0390111A3 (de) Selektive Adenosinrezeptor-Verbindungen
JPS6461461A (en) Benzohetero ring derivative
DE3470883D1 (en) Tetrahydroisoxazolo(4,5-c)pyridine derivatives and preparation thereof
ES2008067T3 (es) Analogos de prostaciclina (pgi2).
EP0882734A3 (de) 5-Deoxy-Cytidin-Derivate
KR950703572A (ko) A-2 수용체 친화성을 갖는 2-치환된 아데노신[2-Substituted adenosines with A-2receptor affinity]
EP0288888A3 (en) Novel glucopyranose derivatives
ATE72443T1 (de) Glucopyranose-derivate.
DE3665715D1 (en) Ergoline derivatives, process for preparing them, pharmaceutical composition and use
ES2061864T3 (es) Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene.
ES2058761T3 (es) Proceso para la preparacion de derivados de dibenzodioxazecina y dibenzodioxaazacicloundecina.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003